What is the latest BAFNAPHARM stock price?
The latest stored price for BAFNAPHARM is Rs n/a as of the latest available market snapshot.
gimli
BAFNAPHARM stock AI analysis
BAFNAPHARM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
BAFNA PHARMACEUTICALS L is a stock in Unclassified. This Gimli page shows the latest available BAFNAPHARM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹n/a
1W return
n/a
1M return
n/a
3M return
n/a
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
n/a
Turnover
₹n/a
Why it can matter in screens
- Momentum: BAFNAPHARM is 50DMA unavailable, 200DMA unavailable; RSI is n/a.
- Returns: 1D n/a, 1W n/a, 1M n/a, 3M n/a, 1Y n/a.
- Trend levels: 52W high ₹n/a, 52W low ₹n/a, off high n/a.
- Liquidity: latest turnover is ₹n/a; volume vs 20D is n/a.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Quick Answers
Is BAFNAPHARM above its 50DMA and 200DMA?
BAFNAPHARM is 50DMA unavailable, 200DMA unavailable. The latest 50DMA is n/a and the latest 200DMA is n/a.
What are BAFNAPHARM PE, ROE and ROCE?
BAFNAPHARM has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.
How has BAFNAPHARM performed recently?
BAFNAPHARM has returned n/a over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
No recent data available.
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
No recent data available.
Try these prompts
- Analyze BAFNA PHARMACEUTICALS L with valuation, momentum and industry peers
- Compare BAFNAPHARM with other Unclassified stocks
- Show stocks in Unclassified above 50DMA with positive 1M return
- Find Unclassified stocks with improving momentum and reasonable valuation
Related screen ideas
- View Unclassified stocks
- View stocks
- Find stocks above 50DMA
- Compare BAFNAPHARM with other Unclassified stocks
Data snapshot: latest available. Not investment advice.